{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "03", "@year": "2023", "@timestamp": "2023-12-03T00:06:42.000042-05:00", "@month": "12"}, "ait:date-sort": {"@day": "14", "@year": "2017", "@month": "01"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Department of Medicine, Faculty of Medicine, Chulalongkorn University", "xocs:funding-id": "5880067"}, {"xocs:funding-agency-matched-string": "Ratchadapiseksompotch Research Fund"}], "xocs:funding-addon-generated-timestamp": "2021-09-16T16:54:07.776Z", "xocs:funding-text": "The authors would like to thank all the study patients for their participating in this study. This work was supported by Ratchadapiseksompotch Research Fund, Department of Medicine, Faculty of Medicine, Chulalongkorn University, and Thailand research fund Career Development Grant #RSA5880067. Thailand. Ergocalciferol, calcitriol, and identical placebo were used in this study were granted from Kaspa Pharmaceutical (Thailand) company.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": {"affiliation": {"country": "Thailand", "address-part": "1873, Rama 4 Rd., Pathumwan", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Nephrology"}, {"$": "Department of Medicine"}, {"$": "King Chulalongkorn Memorial Hospital"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": [{"@afid": "60028190", "@dptid": "113019942"}, {"@afid": "60022183"}], "@dptid": "113019942"}, "author": [{"ce:given-name": "Paweena", "preferred-name": {"ce:given-name": "Paweena", "ce:initials": "P.", "ce:surname": "Susantitaphong", "ce:indexed-name": "Susantitaphong P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Susantitaphong", "@auid": "26025374300", "ce:indexed-name": "Susantitaphong P."}, {"ce:given-name": "Siriwan", "preferred-name": {"ce:given-name": "Siriwan", "ce:initials": "S.", "ce:surname": "Nakwan", "ce:indexed-name": "Nakwan S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Nakwan", "@auid": "57192958706", "ce:indexed-name": "Nakwan S."}, {"ce:given-name": "Sadudee", "preferred-name": {"ce:given-name": "Sadudee", "ce:initials": "S.", "ce:surname": "Peerapornratana", "ce:indexed-name": "Peerapornratana S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Peerapornratana", "@auid": "57076814100", "ce:indexed-name": "Peerapornratana S."}, {"ce:given-name": "Khajohn", "preferred-name": {"ce:given-name": "Khajohn", "ce:initials": "K.", "ce:surname": "Tiranathanagul", "ce:indexed-name": "Tiranathanagul K."}, "@seq": "4", "ce:initials": "K.", "@_fa": "true", "@type": "auth", "ce:surname": "Tiranathanagul", "@auid": "6506178519", "ce:indexed-name": "Tiranathanagul K."}, {"ce:given-name": "Pisut", "preferred-name": {"ce:given-name": "Pisut", "ce:initials": "P.", "ce:surname": "Katavetin", "ce:indexed-name": "Katavetin P."}, "@seq": "5", "ce:initials": "P.", "@date-locked": "2020-06-30T05:51:41.442", "@_fa": "true", "@type": "auth", "ce:surname": "Katavetin", "@auid": "22934697400", "ce:indexed-name": "Katavetin P."}, {"ce:given-name": "Nattachai", "preferred-name": {"ce:given-name": "Nattachai", "ce:initials": "N.", "ce:surname": "Srisawat", "ce:indexed-name": "Srisawat N."}, "@seq": "6", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:surname": "Srisawat", "@auid": "15137204300", "ce:indexed-name": "Srisawat N."}, {"ce:given-name": "Kearkiat", "preferred-name": {"ce:given-name": "Kearkiat", "ce:initials": "K.", "ce:surname": "Praditpornsilpa", "ce:indexed-name": "Praditpornsilpa K."}, "@seq": "7", "ce:initials": "K.", "@_fa": "true", "@type": "auth", "ce:surname": "Praditpornsilpa", "@auid": "6602331011", "ce:indexed-name": "Praditpornsilpa K."}, {"ce:given-name": "Somchai", "preferred-name": {"ce:given-name": "Somchai", "ce:initials": "S.", "ce:surname": "Eiam-Ong", "ce:indexed-name": "Eiam-Ong S."}, "@seq": "8", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Eiam-Ong", "@auid": "7004339510", "ce:indexed-name": "Eiam-Ong S."}]}, "citation-title": "A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria", "abstracts": "\u00a9 2017 The Author(s).Background: KDOQI guideline suggests that nutritional vitamin D should be supplemented in chronic kidney disease (CKD) patients who have vitamin D insufficiency/deficiency. However, there are scarce data regarding the additional benefit of active vitamin D supplement in CKD patients who were receiving nutritional vitamin D supplement. This study was conducted to explore the effect of adding active vitamin D to nutritional vitamin D supplement on proteinuria and kidney function in CKD with vitamin D insufficiency/deficiency. Methods: This double-blind, randomized placebo-controlled trial was performed to answer the above question. Sixty-eight patients with CKD stage 3-4, urine protein to creatinine ratio (UPCR) > 1 g/g, and serum 25OH-D level < 30 ng/mL were enrolled. Patients were randomly assigned to receive 12-week treatment with oral ergocalciferol plus placebo (n = 36) or oral ergocalciferol plus calcitriol (n = 32). Results: The mean baseline values of UPCR of both groups were comparable (3.6 \u00b1 3.8 g/g in combined group and 3.5 \u00b1 3.0 g/g in ergocalciferol group). Following 12-week treatment, there were significant reductions in UPCR from baseline in both groups (2.3 \u00b1 2.1 g/g in combined group and 2.4 \u00b1 2.0 g/g in ergocalciferol group). The percentage reductions in UPCR of both groups were not significantly different. The mean eGFR and blood pressure did not differ between baseline and 12-week follow-up and between both groups. No severe hypercalcemia or serious side effects were noted in both groups. Conclusions: The proteinuria lowering effect of ergocalciferol in CKD patients with vitamin D deficiency was demonstrated. Additional calcitriol supplement did not have more effects on proteinuria. Trial registration: (Thai Clinical Trials Registry (TCTR) 20140929002). Date of registration: September 27, 2014.", "correspondence": {"affiliation": {"country": "Thailand", "address-part": "1873, Rama 4 Rd., Pathumwan", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Nephrology"}, {"$": "Department of Medicine"}, {"$": "King Chulalongkorn Memorial Hospital"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Paweena", "ce:initials": "P.", "ce:surname": "Susantitaphong", "ce:indexed-name": "Susantitaphong P."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Calcitriol", "@xml:lang": "eng"}, {"$": "CKD", "@xml:lang": "eng"}, {"$": "Ergocalciferol", "@xml:lang": "eng"}, {"$": "Proteinuria", "@xml:lang": "eng"}, {"$": "Vitamin D deficiency", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://www.biomedcentral.com/bmcnephrol/", "@type": "email"}}, "translated-sourcetitle": {"$": "BMC Nephrology", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "18", "@issue": "1"}}, "@type": "j", "sourcetitle": "BMC Nephrology", "publicationdate": {"month": "01", "year": "2017", "date-text": {"@xfab-added": "true", "$": "14 January 2017"}, "day": "14"}, "sourcetitle-abbrev": "BMC Nephrol.", "@country": "gbr", "issn": {"$": "14712369", "@type": "electronic"}, "publicationyear": {"@first": "2017"}, "publisher": {"publishername": "BioMed Central Ltd.", "ce:e-address": {"$": "info@biomedcentral.com", "@type": "email"}}, "article-number": "19", "@srcid": "19395"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "28", "classification-description": "Urology and Nephrology"}, {"classification-code": "29", "classification-description": "Clinical and Experimental Biochemistry"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}]}, {"@type": "ASJC", "classification": "2727"}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "64719-49-9", "chemical-name": "25 hydroxyvitamin D"}, {"cas-registry-number": [{"$": "32222-06-3"}, {"$": "32511-63-0"}, {"$": "66772-14-3"}], "chemical-name": "calcitriol"}, {"cas-registry-number": [{"$": "19230-81-0"}, {"$": "60-27-5"}], "chemical-name": "creatinine"}, {"cas-registry-number": [{"$": "50-14-6"}, {"$": "50809-47-7"}, {"$": "8042-78-2"}], "chemical-name": "ergocalciferol"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "25-hydroxyvitamin D"}, {"chemical-name": "Calcitriol"}, {"chemical-name": "Creatinine"}, {"chemical-name": "Ergocalciferols"}, {"chemical-name": "Vitamin D"}, {"chemical-name": "Vitamins"}]}]}}, "grantlist": {"@complete": "y", "grant-text": {"$": "This work was supported by Ratchadapiseksompotch Research Fund, Department of Medicine, Faculty of Medicine, Chulalongkorn University, and Thailand research fund Career Development Grant #RSA5880067", "@xml:lang": "eng"}, "grant": {"grant-id": "RSA5880067", "grant-acronym": "CU", "grant-agency": "Chulalongkorn University"}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}, {"$": "MEDL"}], "history": {"date-created": {"@day": "31", "@year": "2017", "@timestamp": "BST 12:21:45", "@month": "01"}}, "itemidlist": {"itemid": [{"$": "614054464", "@idtype": "PUI"}, {"$": "660045464", "@idtype": "CAR-ID"}, {"$": "20170050463", "@idtype": "EMBASE"}, {"$": "20170117504", "@idtype": "REAXYSCAR"}, {"$": "2017020309", "@idtype": "RMC"}, {"$": "85009511178", "@idtype": "SCP"}, {"$": "85009511178", "@idtype": "SGR"}, {"$": "619662300", "@idtype": "PUIsecondary"}, {"$": "28088187", "@idtype": "MEDL"}], "ce:doi": "10.1186/s12882-017-0436-6"}}, "tail": {"bibliography": {"@refcount": "28", "reference": [{"ref-fulltext": "Stanifer JW, Muiru A, Jafar TH, Patel UD. Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant. 2016;31(6):868-74. doi: 10.1093/ndt/gfv466. Epub 2016 Feb 4.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Chronic kidney disease in low- and middle-income countries"}, "refd-itemidlist": {"itemid": {"$": "84975109820", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "31", "@issue": "6"}, "pagerange": {"@first": "868", "@last": "874"}}, "ref-text": "10.1093/ndt/gfv466 27217391 Epub 2016 Feb 4", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.W.", "@_fa": "true", "ce:surname": "Stanifer", "ce:indexed-name": "Stanifer J.W."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Muiru", "ce:indexed-name": "Muiru A."}, {"@seq": "3", "ce:initials": "T.H.", "@_fa": "true", "ce:surname": "Jafar", "ce:indexed-name": "Jafar T.H."}, {"@seq": "4", "ce:initials": "U.D.", "@_fa": "true", "ce:surname": "Patel", "ce:indexed-name": "Patel U.D."}]}, "ref-sourcetitle": "Nephrol Dial Transplant"}}, {"ref-fulltext": "Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int. 2011;79:1331-40.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts"}, "refd-itemidlist": {"itemid": {"$": "79957827666", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "79"}, "pagerange": {"@first": "1331", "@last": "1340"}}, "ref-text": "1:CAS:528:DC%2BC3MXmvFyjsbs%3D 21289598", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.C.", "@_fa": "true", "ce:surname": "Astor", "ce:indexed-name": "Astor B.C."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Matsushita", "ce:indexed-name": "Matsushita K."}, {"@seq": "3", "ce:initials": "R.T.", "@_fa": "true", "ce:surname": "Gansevoort", "ce:indexed-name": "Gansevoort R.T."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Van Der Velde", "ce:indexed-name": "Van Der Velde M."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Woodward", "ce:indexed-name": "Woodward M."}, {"@seq": "6", "ce:initials": "A.S.", "@_fa": "true", "ce:surname": "Levey", "ce:indexed-name": "Levey A.S."}], "et-al": null}, "ref-sourcetitle": "Kidney Int"}}, {"ref-fulltext": "Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31-8.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Prevalence of abnormal serum Vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease"}, "refd-itemidlist": {"itemid": {"$": "33845700085", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "71"}, "pagerange": {"@first": "31", "@last": "38"}}, "ref-text": "1:CAS:528:DC%2BD28XhtlSqtbnK 17091124", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Levin", "ce:indexed-name": "Levin A."}, {"@seq": "2", "ce:initials": "G.L.", "@_fa": "true", "ce:surname": "Bakris", "ce:indexed-name": "Bakris G.L."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Molitch", "ce:indexed-name": "Molitch M."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Smulders", "ce:indexed-name": "Smulders M."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Tian", "ce:indexed-name": "Tian J."}, {"@seq": "6", "ce:initials": "L.A.", "@_fa": "true", "ce:surname": "Williams", "ce:indexed-name": "Williams L.A."}], "et-al": null}, "ref-sourcetitle": "Kidney Int"}}, {"ref-fulltext": "National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1-201.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease"}, "refd-itemidlist": {"itemid": {"$": "83055172414", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "42"}, "pagerange": {"@first": "S1", "@last": "201"}}, "ref-text": "National Kidney Foundation", "ref-sourcetitle": "Am J Kidney Dis"}}, {"ref-fulltext": "Susantitaphong P, Eiam-Ong S. Role of Vitamin D in Chronic Kidney Disease. Asian Biomed. (in press).", "@id": "5", "ref-info": {"ref-title": {"ref-titletext": "Role of Vitamin D in Chronic Kidney Disease"}, "refd-itemidlist": {"itemid": {"$": "85009444214", "@idtype": "SGR"}}, "ref-text": "(in press).", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Susantitaphong", "ce:indexed-name": "Susantitaphong P."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Eiam-Ong", "ce:indexed-name": "Eiam-Ong S."}]}, "ref-sourcetitle": "Asian Biomed"}}, {"ref-fulltext": "Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Sikaris KA, et al. Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis. 2013;62:58-66.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD"}, "refd-itemidlist": {"itemid": {"$": "84879422068", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "62"}, "pagerange": {"@first": "58", "@last": "66"}}, "ref-text": "1:CAS:528:DC%2BC3sXms1Kltb8%3D 23623574", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Damasiewicz", "ce:indexed-name": "Damasiewicz M.J."}, {"@seq": "2", "ce:initials": "D.J.", "@_fa": "true", "ce:surname": "Magliano", "ce:indexed-name": "Magliano D.J."}, {"@seq": "3", "ce:initials": "R.M.", "@_fa": "true", "ce:surname": "Daly", "ce:indexed-name": "Daly R.M."}, {"@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Gagnon", "ce:indexed-name": "Gagnon C."}, {"@seq": "5", "ce:initials": "Z.X.", "@_fa": "true", "ce:surname": "Lu", "ce:indexed-name": "Lu Z.X."}, {"@seq": "6", "ce:initials": "K.A.", "@_fa": "true", "ce:surname": "Sikaris", "ce:indexed-name": "Sikaris K.A."}], "et-al": null}, "ref-sourcetitle": "Am J Kidney Dis"}}, {"ref-fulltext": "Satirapoj B, Limwannata P, Chaiprasert A, Supasyndh O, Choovichian P. Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population. BMC Nephrol. 2013;14:206.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population"}, "refd-itemidlist": {"itemid": {"$": "84884800866", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14"}, "pagerange": {"@first": "206"}}, "ref-text": "24083392 3850679", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Satirapoj", "ce:indexed-name": "Satirapoj B."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Limwannata", "ce:indexed-name": "Limwannata P."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Chaiprasert", "ce:indexed-name": "Chaiprasert A."}, {"@seq": "4", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Supasyndh", "ce:indexed-name": "Supasyndh O."}, {"@seq": "5", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Choovichian", "ce:indexed-name": "Choovichian P."}]}, "ref-sourcetitle": "BMC Nephrol"}}, {"ref-fulltext": "Izumaru K, Ninomiya T, Nagata M, Usui T, Yoshida D, Yonemoto K, et al. Serum 1,25-dihydroxyvitamin d and the development of kidney dysfunction in a Japanese community. Circ J. 2014;78:732-7.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Serum 1,25-dihydroxyvitamin d and the development of kidney dysfunction in a Japanese community"}, "refd-itemidlist": {"itemid": {"$": "84894472852", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "78"}, "pagerange": {"@first": "732", "@last": "737"}}, "ref-text": "1:CAS:528:DC%2BC2cXntlGjs7g%3D 24351652", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Izumaru", "ce:indexed-name": "Izumaru K."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Ninomiya", "ce:indexed-name": "Ninomiya T."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Nagata", "ce:indexed-name": "Nagata M."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Usui", "ce:indexed-name": "Usui T."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Yoshida", "ce:indexed-name": "Yoshida D."}, {"@seq": "6", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Yonemoto", "ce:indexed-name": "Yonemoto K."}], "et-al": null}, "ref-sourcetitle": "Circ J"}}, {"ref-fulltext": "Fernandez-Juarez G, Luno J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, et al. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system. Clin J Am SocNephrol. 2013;8:1870-6.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "25 (OH) Vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system"}, "refd-itemidlist": {"itemid": {"$": "84887301184", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "1870", "@last": "1876"}}, "ref-text": "1:CAS:528:DC%2BC3sXhvVCjsLbE", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Fernandez-Juarez", "ce:indexed-name": "Fernandez-Juarez G."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Luno", "ce:indexed-name": "Luno J."}, {"@seq": "3", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Barrio", "ce:indexed-name": "Barrio V."}, {"@seq": "4", "ce:initials": "S.G.", "@_fa": "true", "ce:surname": "De Vinuesa", "ce:indexed-name": "De Vinuesa S.G."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Praga", "ce:indexed-name": "Praga M."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Goicoechea", "ce:indexed-name": "Goicoechea M."}], "et-al": null}, "ref-sourcetitle": "Clin J Am SocNephrol"}}, {"ref-fulltext": "Molina P, Gorriz JL, Molina MD, Peris A, Beltran S, Kanter J, et al. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Nephrol Dial Transplant. 2014;29:97-109.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: A prospective controlled study"}, "refd-itemidlist": {"itemid": {"$": "84891020938", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "97", "@last": "109"}}, "ref-text": "1:CAS:528:DC%2BC2cXmt1yqtg%3D%3D 23975842", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Molina", "ce:indexed-name": "Molina P."}, {"@seq": "2", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Gorriz", "ce:indexed-name": "Gorriz J.L."}, {"@seq": "3", "ce:initials": "M.D.", "@_fa": "true", "ce:surname": "Molina", "ce:indexed-name": "Molina M.D."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Peris", "ce:indexed-name": "Peris A."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Beltran", "ce:indexed-name": "Beltran S."}, {"@seq": "6", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Kanter", "ce:indexed-name": "Kanter J."}], "et-al": null}, "ref-sourcetitle": "Nephrol Dial Transplant"}}, {"ref-fulltext": "Kim MJ, Frankel AH, Donaldson M, Darch SJ, Pusey CD, Hill PD, et al. Oral cholecalciferol decreases albuminuria and urinary TGF-\u03b21 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int. 2011;80(8):851-60.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Oral cholecalciferol decreases albuminuria and urinary TGF-\u03b21 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition"}, "refd-itemidlist": {"itemid": {"$": "80053571782", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "80", "@issue": "8"}, "pagerange": {"@first": "851", "@last": "860"}}, "ref-text": "1:CAS:528:DC%2BC3MXht1GiurnN 21832985", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim M.J."}, {"@seq": "2", "ce:initials": "A.H.", "@_fa": "true", "ce:surname": "Frankel", "ce:indexed-name": "Frankel A.H."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Donaldson", "ce:indexed-name": "Donaldson M."}, {"@seq": "4", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Darch", "ce:indexed-name": "Darch S.J."}, {"@seq": "5", "ce:initials": "C.D.", "@_fa": "true", "ce:surname": "Pusey", "ce:indexed-name": "Pusey C.D."}, {"@seq": "6", "ce:initials": "P.D.", "@_fa": "true", "ce:surname": "Hill", "ce:indexed-name": "Hill P.D."}], "et-al": null}, "ref-sourcetitle": "Kidney Int"}}, {"ref-fulltext": "Kim CS, Kim SW. Vitamin D and chronic kidney disease. Korean J Intern Med. 2014;29:416-27.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Vitamin D and chronic kidney disease"}, "refd-itemidlist": {"itemid": {"$": "84904571453", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "416", "@last": "427"}}, "ref-text": "1:CAS:528:DC%2BC2cXhsl2mtrzF 25045287 4101586", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.S.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim C.S."}, {"@seq": "2", "ce:initials": "S.W.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim S.W."}]}, "ref-sourcetitle": "Korean J Intern Med"}}, {"ref-fulltext": "Krairittichai U, Mahannopkul R, Bunnag S. An open-label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease. J Med Assoc Thai. 2012;95 Suppl 3:S41-7.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "An open-label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease"}, "refd-itemidlist": {"itemid": {"$": "84862595289", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "95"}, "pagerange": {"@first": "S41", "@last": "S47"}}, "ref-text": "22619886", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Krairittichai", "ce:indexed-name": "Krairittichai U."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Mahannopkul", "ce:indexed-name": "Mahannopkul R."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Bunnag", "ce:indexed-name": "Bunnag S."}]}, "ref-sourcetitle": "J Med Assoc Thai"}}, {"ref-fulltext": "Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial. Am J Kidney Dis. 2008;51:724-31.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: An uncontrolled trial"}, "refd-itemidlist": {"itemid": {"$": "43049104680", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "51"}, "pagerange": {"@first": "724", "@last": "731"}}, "ref-text": "1:CAS:528:DC%2BD1cXmsFejur8%3D 18436082", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.C.", "@_fa": "true", "ce:surname": "Szeto", "ce:indexed-name": "Szeto C.C."}, {"@seq": "2", "ce:initials": "K.M.", "@_fa": "true", "ce:surname": "Chow", "ce:indexed-name": "Chow K.M."}, {"@seq": "3", "ce:initials": "B.C.", "@_fa": "true", "ce:surname": "Kwan", "ce:indexed-name": "Kwan B.C."}, {"@seq": "4", "ce:initials": "K.Y.", "@_fa": "true", "ce:surname": "Chung", "ce:indexed-name": "Chung K.Y."}, {"@seq": "5", "ce:initials": "C.B.", "@_fa": "true", "ce:surname": "Leung", "ce:indexed-name": "Leung C.B."}, {"@seq": "6", "ce:initials": "P.K.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li P.K."}]}, "ref-sourcetitle": "Am J Kidney Dis"}}, {"ref-fulltext": "Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, et al. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 2005;68:2823-8.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Antiproteinuric effect of oral paricalcitol in chronic kidney disease"}, "refd-itemidlist": {"itemid": {"$": "32844466369", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "68"}, "pagerange": {"@first": "2823", "@last": "2828"}}, "ref-text": "1:CAS:528:DC%2BD28XhslWjug%3D%3D 16316359", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Agarwal", "ce:indexed-name": "Agarwal R."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Acharya", "ce:indexed-name": "Acharya M."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Tian", "ce:indexed-name": "Tian J."}, {"@seq": "4", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Hippensteel", "ce:indexed-name": "Hippensteel R.L."}, {"@seq": "5", "ce:initials": "J.Z.", "@_fa": "true", "ce:surname": "Melnick", "ce:indexed-name": "Melnick J.Z."}, {"@seq": "6", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Qiu", "ce:indexed-name": "Qiu P."}], "et-al": null}, "ref-sourcetitle": "Kidney Int"}}, {"ref-fulltext": "Praditpornsilpa K, Townamchai N, Chaiwatanarat T, Tiranathanagul K, Katawatin P, Susantitaphong P, et al. The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations. Nephrol Dial Transplant. 2011;26:2780-5.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations"}, "refd-itemidlist": {"itemid": {"$": "79961058078", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "26"}, "pagerange": {"@first": "2780", "@last": "2785"}}, "ref-text": "21357214", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Praditpornsilpa", "ce:indexed-name": "Praditpornsilpa K."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Townamchai", "ce:indexed-name": "Townamchai N."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Chaiwatanarat", "ce:indexed-name": "Chaiwatanarat T."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Tiranathanagul", "ce:indexed-name": "Tiranathanagul K."}, {"@seq": "5", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Katawatin", "ce:indexed-name": "Katawatin P."}, {"@seq": "6", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Susantitaphong", "ce:indexed-name": "Susantitaphong P."}], "et-al": null}, "ref-sourcetitle": "Nephrol Dial Transplant"}}, {"ref-fulltext": "Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2:337-414.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease"}, "refd-itemidlist": {"itemid": {"$": "84884293874", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "337", "@last": "414"}}, "ref-text": "Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group", "ref-sourcetitle": "Kidney Int Suppl"}}, {"ref-fulltext": "de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010;376:1543-51.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Selective Vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): A randomised controlled trial"}, "refd-itemidlist": {"itemid": {"$": "78149359262", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "376"}, "pagerange": {"@first": "1543", "@last": "1551"}}, "ref-text": "21055801", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "De Zeeuw", "ce:indexed-name": "De Zeeuw D."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Agarwal", "ce:indexed-name": "Agarwal R."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Amdahl", "ce:indexed-name": "Amdahl M."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Audhya", "ce:indexed-name": "Audhya P."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Coyne", "ce:indexed-name": "Coyne D."}, {"@seq": "6", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Garimella", "ce:indexed-name": "Garimella T."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJ. Active vitamin D treatment for reduction of residual proteinuria: a systematic review. J Am SocNephrol. 2013;24:1863-71.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Active Vitamin D treatment for reduction of residual proteinuria: A systematic review"}, "refd-itemidlist": {"itemid": {"$": "84887105515", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "1863", "@last": "1871"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "De Borst", "ce:indexed-name": "De Borst M.H."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Hajhosseiny", "ce:indexed-name": "Hajhosseiny R."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Tamez", "ce:indexed-name": "Tamez H."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Wenger", "ce:indexed-name": "Wenger J."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Thadhani", "ce:indexed-name": "Thadhani R."}, {"@seq": "6", "ce:initials": "D.J.", "@_fa": "true", "ce:surname": "Goldsmith", "ce:indexed-name": "Goldsmith D.J."}]}, "ref-sourcetitle": "J Am SocNephrol"}}, {"ref-fulltext": "Xu L, Wan X, Huang Z, Zeng F, Wei G, Fang D, et al. Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials. PLoS One. 2013;8:e61387.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Impact of Vitamin D on chronic kidney diseases in non-dialysis patients: A meta-analysis of randomized controlled trials"}, "refd-itemidlist": {"itemid": {"$": "84876528916", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "e61387"}}, "ref-text": "1:CAS:528:DC%2BC3sXntVKrtrY%3D 23626678 3634086", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Xu", "ce:indexed-name": "Xu L."}, {"@seq": "2", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Wan", "ce:indexed-name": "Wan X."}, {"@seq": "3", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Huang", "ce:indexed-name": "Huang Z."}, {"@seq": "4", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Zeng", "ce:indexed-name": "Zeng F."}, {"@seq": "5", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Wei", "ce:indexed-name": "Wei G."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Fang", "ce:indexed-name": "Fang D."}], "et-al": null}, "ref-sourcetitle": "PLoS One"}}, {"ref-fulltext": "Freundlich M, Quiroz Y, Zhang Z, et al. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int. 2008;74(11):1394-402.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Suppression of renin-angiotensin gene expression in the kidney by paricalcitol"}, "refd-itemidlist": {"itemid": {"$": "56549101354", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "74", "@issue": "11"}, "pagerange": {"@first": "1394", "@last": "1402"}}, "ref-text": "1:CAS:528:DC%2BD1cXhtlOjtrvI 18813285", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Freundlich", "ce:indexed-name": "Freundlich M."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Quiroz", "ce:indexed-name": "Quiroz Y."}, {"@seq": "3", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang Z."}], "et-al": null}, "ref-sourcetitle": "Kidney Int"}}, {"ref-fulltext": "Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-38.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system"}, "refd-itemidlist": {"itemid": {"$": "0036073755", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "110", "@issue": "2"}, "pagerange": {"@first": "229", "@last": "238"}}, "ref-text": "1:CAS:528:DC%2BD38XlsVGlsbg%3D 12122115 151055", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.C.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li Y.C."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Kong", "ce:indexed-name": "Kong J."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Wei", "ce:indexed-name": "Wei M."}, {"@seq": "4", "ce:initials": "Z.F.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen Z.F."}, {"@seq": "5", "ce:initials": "S.Q.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu S.Q."}, {"@seq": "6", "ce:initials": "L.P.", "@_fa": "true", "ce:surname": "Cao", "ce:indexed-name": "Cao L.P."}]}, "ref-sourcetitle": "J Clin Invest"}}, {"ref-fulltext": "Chesney RW. Interactions of vitamin D and the proximal tubule. Pediatr Nephrol. 2016;31(1):7-14.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Interactions of Vitamin D and the proximal tubule"}, "refd-itemidlist": {"itemid": {"$": "84947487057", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "31", "@issue": "1"}, "pagerange": {"@first": "7", "@last": "14"}}, "ref-text": "25618772", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.W.", "@_fa": "true", "ce:surname": "Chesney", "ce:indexed-name": "Chesney R.W."}]}, "ref-sourcetitle": "Pediatr Nephrol"}}, {"ref-fulltext": "Kim CS, Joo SY, Lee KE, Choi JS, Bae EH, Ma SK, Kim SH, Lee J, Kim SW. Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. PLoS One. 2013;8(5):e63186. doi: 10.1371/journal.pone.0063186.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells"}, "refd-itemidlist": {"itemid": {"$": "84877869622", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8", "@issue": "5"}, "pagerange": {"@first": "e63186"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.S.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim C.S."}, {"@seq": "2", "ce:initials": "S.Y.", "@_fa": "true", "ce:surname": "Joo", "ce:indexed-name": "Joo S.Y."}, {"@seq": "3", "ce:initials": "K.E.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee K.E."}, {"@seq": "4", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Choi", "ce:indexed-name": "Choi J.S."}, {"@seq": "5", "ce:initials": "E.H.", "@_fa": "true", "ce:surname": "Bae", "ce:indexed-name": "Bae E.H."}, {"@seq": "6", "ce:initials": "S.K.", "@_fa": "true", "ce:surname": "Ma", "ce:indexed-name": "Ma S.K."}, {"@seq": "7", "ce:initials": "S.H.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim S.H."}, {"@seq": "8", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee J."}, {"@seq": "9", "ce:initials": "S.W.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim S.W."}]}, "ref-sourcetitle": "PLoS One"}}, {"ref-fulltext": "Mathieu C, Adorini L. The coming of age of 1,25- dihydroxy vitamin D(3) analogs as immunomodulatory agents. Trends Mol Med. 2002;8(4):174-9.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "The coming of age of 1,25- dihydroxy Vitamin D(3) analogs as immunomodulatory agents"}, "refd-itemidlist": {"itemid": {"$": "0036220629", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "8", "@issue": "4"}, "pagerange": {"@first": "174", "@last": "179"}}, "ref-text": "1:CAS:528:DC%2BD38XitlGhsbk%3D 11927275", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Mathieu", "ce:indexed-name": "Mathieu C."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Adorini", "ce:indexed-name": "Adorini L."}]}, "ref-sourcetitle": "Trends Mol Med"}}, {"ref-fulltext": "Schwarz U, Amann K, Orth SR, Simonaviciene A, Wessels S, Ritz E. Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int. 1998;53(6):1696-705.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats"}, "refd-itemidlist": {"itemid": {"$": "0031749608", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "53", "@issue": "6"}, "pagerange": {"@first": "1696", "@last": "1705"}}, "ref-text": "1:CAS:528:DyaK1cXjs12lsrc%3D 9607202", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Schwarz", "ce:indexed-name": "Schwarz U."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Amann", "ce:indexed-name": "Amann K."}, {"@seq": "3", "ce:initials": "S.R.", "@_fa": "true", "ce:surname": "Orth", "ce:indexed-name": "Orth S.R."}, {"@seq": "4", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Simonaviciene", "ce:indexed-name": "Simonaviciene A."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Wessels", "ce:indexed-name": "Wessels S."}, {"@seq": "6", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Ritz", "ce:indexed-name": "Ritz E."}]}, "ref-sourcetitle": "Kidney Int"}}, {"ref-fulltext": "Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1-130.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)"}, "refd-itemidlist": {"itemid": {"$": "68949114585", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "113"}, "pagerange": {"@first": "S1", "@last": "130"}}, "ref-text": "Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group", "ref-sourcetitle": "Kidney Int Suppl"}}, {"ref-fulltext": "Porter A, Gilmartin C, Srisakul U, Arruda J, Akkina S. Prevalence of 25-OH vitamin D deficiency in a population of hemodialysis patients and efficacy of an oral ergocalciferol supplementation regimen. Am J Nephrol. 2013;37:568-74.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Prevalence of 25-OH Vitamin D deficiency in a population of hemodialysis patients and efficacy of an oral ergocalciferol supplementation regimen"}, "refd-itemidlist": {"itemid": {"$": "84878367715", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "37"}, "pagerange": {"@first": "568", "@last": "574"}}, "ref-text": "1:CAS:528:DC%2BC3sXhtVylu7nL 23735861 4109679", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Porter", "ce:indexed-name": "Porter A."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Gilmartin", "ce:indexed-name": "Gilmartin C."}, {"@seq": "3", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Srisakul", "ce:indexed-name": "Srisakul U."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Arruda", "ce:indexed-name": "Arruda J."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Akkina", "ce:indexed-name": "Akkina S."}]}, "ref-sourcetitle": "Am J Nephrol"}}]}}}}, "affiliation": {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, "coredata": {"srctype": "j", "eid": "2-s2.0-85009511178", "dc:description": "Background: KDOQI guideline suggests that nutritional vitamin D should be supplemented in chronic kidney disease (CKD) patients who have vitamin D insufficiency/deficiency. However, there are scarce data regarding the additional benefit of active vitamin D supplement in CKD patients who were receiving nutritional vitamin D supplement. This study was conducted to explore the effect of adding active vitamin D to nutritional vitamin D supplement on proteinuria and kidney function in CKD with vitamin D insufficiency/deficiency. Methods: This double-blind, randomized placebo-controlled trial was performed to answer the above question. Sixty-eight patients with CKD stage 3-4, urine protein to creatinine ratio (UPCR) > 1 g/g, and serum 25OH-D level < 30 ng/mL were enrolled. Patients were randomly assigned to receive 12-week treatment with oral ergocalciferol plus placebo (n = 36) or oral ergocalciferol plus calcitriol (n = 32). Results: The mean baseline values of UPCR of both groups were comparable (3.6 \u00b1 3.8 g/g in combined group and 3.5 \u00b1 3.0 g/g in ergocalciferol group). Following 12-week treatment, there were significant reductions in UPCR from baseline in both groups (2.3 \u00b1 2.1 g/g in combined group and 2.4 \u00b1 2.0 g/g in ergocalciferol group). The percentage reductions in UPCR of both groups were not significantly different. The mean eGFR and blood pressure did not differ between baseline and 12-week follow-up and between both groups. No severe hypercalcemia or serious side effects were noted in both groups. Conclusions: The proteinuria lowering effect of ergocalciferol in CKD patients with vitamin D deficiency was demonstrated. Additional calcitriol supplement did not have more effects on proteinuria. Trial registration: (Thai Clinical Trials Registry (TCTR) 20140929002). Date of registration: September 27, 2014.", "pubmed-id": "28088187", "prism:coverDate": "2017-01-14", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85009511178", "dc:creator": {"author": [{"ce:given-name": "Paweena", "preferred-name": {"ce:given-name": "Paweena", "ce:initials": "P.", "ce:surname": "Susantitaphong", "ce:indexed-name": "Susantitaphong P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Susantitaphong", "@auid": "26025374300", "author-url": "https://api.elsevier.com/content/author/author_id/26025374300", "ce:indexed-name": "Susantitaphong P."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85009511178"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85009511178&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85009511178&origin=inward"}], "source-id": "19395", "citedby-count": "13", "prism:volume": "18", "subtype": "ar", "dc:title": "A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria", "openaccess": "1", "prism:issn": "14712369", "publishercopyright": "\u00a9 2017 The Author(s).", "article-number": "19", "prism:issueIdentifier": "1", "subtypeDescription": "Article", "prism:publicationName": "BMC Nephrology", "openaccessFlag": "true", "prism:doi": "10.1186/s12882-017-0436-6", "dc:identifier": "SCOPUS_ID:85009511178", "dc:publisher": "BioMed Central Ltd.info@biomedcentral.com"}, "idxterms": {"mainterm": [{"$": "Aged", "@weight": "b", "@candidate": "n"}, {"$": "Blood Pressure", "@weight": "b", "@candidate": "n"}, {"$": "Calcitriol", "@weight": "b", "@candidate": "n"}, {"$": "Creatinine", "@weight": "b", "@candidate": "n"}, {"$": "Double-Blind Method", "@weight": "b", "@candidate": "n"}, {"$": "Drug Therapy, Combination", "@weight": "b", "@candidate": "n"}, {"$": "Ergocalciferols", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Glomerular Filtration Rate", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Proteinuria", "@weight": "b", "@candidate": "n"}, {"$": "Renal Insufficiency, Chronic", "@weight": "b", "@candidate": "n"}, {"$": "Severity of Illness Index", "@weight": "b", "@candidate": "n"}, {"$": "Thailand", "@weight": "b", "@candidate": "n"}, {"$": "Treatment Outcome", "@weight": "b", "@candidate": "n"}, {"$": "Vitamin D", "@weight": "b", "@candidate": "n"}, {"$": "Vitamin D Deficiency", "@weight": "b", "@candidate": "n"}, {"$": "Vitamins", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Calcitriol"}, {"@_fa": "true", "$": "CKD"}, {"@_fa": "true", "$": "Ergocalciferol"}, {"@_fa": "true", "$": "Proteinuria"}, {"@_fa": "true", "$": "Vitamin D deficiency"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Nephrology", "@code": "2727", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Paweena", "preferred-name": {"ce:given-name": "Paweena", "ce:initials": "P.", "ce:surname": "Susantitaphong", "ce:indexed-name": "Susantitaphong P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Susantitaphong", "@auid": "26025374300", "author-url": "https://api.elsevier.com/content/author/author_id/26025374300", "ce:indexed-name": "Susantitaphong P."}, {"ce:given-name": "Siriwan", "preferred-name": {"ce:given-name": "Siriwan", "ce:initials": "S.", "ce:surname": "Nakwan", "ce:indexed-name": "Nakwan S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Nakwan", "@auid": "57192958706", "author-url": "https://api.elsevier.com/content/author/author_id/57192958706", "ce:indexed-name": "Nakwan S."}, {"ce:given-name": "Sadudee", "preferred-name": {"ce:given-name": "Sadudee", "ce:initials": "S.", "ce:surname": "Peerapornratana", "ce:indexed-name": "Peerapornratana S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Peerapornratana", "@auid": "57076814100", "author-url": "https://api.elsevier.com/content/author/author_id/57076814100", "ce:indexed-name": "Peerapornratana S."}, {"ce:given-name": "Khajohn", "preferred-name": {"ce:given-name": "Khajohn", "ce:initials": "K.", "ce:surname": "Tiranathanagul", "ce:indexed-name": "Tiranathanagul K."}, "@seq": "4", "ce:initials": "K.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Tiranathanagul", "@auid": "6506178519", "author-url": "https://api.elsevier.com/content/author/author_id/6506178519", "ce:indexed-name": "Tiranathanagul K."}, {"ce:given-name": "Pisut", "preferred-name": {"ce:given-name": "Pisut", "ce:initials": "P.", "ce:surname": "Katavetin", "ce:indexed-name": "Katavetin P."}, "@seq": "5", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Katavetin", "@auid": "22934697400", "author-url": "https://api.elsevier.com/content/author/author_id/22934697400", "ce:indexed-name": "Katavetin P."}, {"ce:given-name": "Nattachai", "preferred-name": {"ce:given-name": "Nattachai", "ce:initials": "N.", "ce:surname": "Srisawat", "ce:indexed-name": "Srisawat N."}, "@seq": "6", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Srisawat", "@auid": "15137204300", "author-url": "https://api.elsevier.com/content/author/author_id/15137204300", "ce:indexed-name": "Srisawat N."}, {"ce:given-name": "Kearkiat", "preferred-name": {"ce:given-name": "Kearkiat", "ce:initials": "K.", "ce:surname": "Praditpornsilpa", "ce:indexed-name": "Praditpornsilpa K."}, "@seq": "7", "ce:initials": "K.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Praditpornsilpa", "@auid": "6602331011", "author-url": "https://api.elsevier.com/content/author/author_id/6602331011", "ce:indexed-name": "Praditpornsilpa K."}, {"ce:given-name": "Somchai", "preferred-name": {"ce:given-name": "Somchai", "ce:initials": "S.", "ce:surname": "Eiam-Ong", "ce:indexed-name": "Eiam-Ong S."}, "@seq": "8", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Eiam-Ong", "@auid": "7004339510", "author-url": "https://api.elsevier.com/content/author/author_id/7004339510", "ce:indexed-name": "Eiam-Ong S."}]}}}